BeOne Medicines (ONC) Enterprise Value Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.73% |
| Dec 31, 2025 | -0.09% |
| Sep 30, 2025 | -66.65% |
| Jun 30, 2025 | 21.53% |
| Mar 31, 2025 | -9.86% |
| Dec 31, 2024 | -5.43% |
| Sep 30, 2024 | 11.64% |
| Jun 30, 2024 | 16.05% |
| Mar 31, 2024 | 1.36% |
| Dec 31, 2023 | 11.95% |
| Sep 30, 2023 | 12.26% |
| Jun 30, 2023 | -25.06% |
| Mar 31, 2023 | -39.81% |
| Dec 31, 2022 | -67.41% |
| Sep 30, 2022 | -32.58% |
| Jun 30, 2022 | -109.99% |
| Mar 31, 2022 | -30.70% |
| Dec 31, 2021 | -28.02% |
| Sep 30, 2021 | -41.18% |
| Jun 30, 2021 | -47.84% |
| Mar 31, 2021 | -43.92% |
| Dec 31, 2020 | -78.11% |
| Sep 30, 2020 | -84.92% |
| Jun 30, 2020 | -66.00% |
| Mar 31, 2020 | -62.40% |
| Dec 31, 2019 | -37.95% |
| Sep 30, 2019 | -22.50% |
| Jun 30, 2019 | -39.56% |
| Mar 31, 2019 | -50.94% |
| Dec 31, 2018 | -119.91% |
| Sep 30, 2018 | -270.13% |
| Jun 30, 2018 | -277.77% |
| Mar 31, 2018 | -318.04% |